Journal article
A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
Abstract
BackgroundThere is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and obtain consent from eligible APS patients and to obtain 95% adherence with daily rivaroxaban administration, in order to inform and power a larger study. Clinical outcomes of bleeding and thrombosis were also …
Authors
Legault K; Blostein M; Carrier M; Kahn S; Schulman S; Shivakumar S; Wu C; Crowther MA
Journal
Pilot and Feasibility Studies, Vol. 6, No. 1,
Publisher
Springer Nature
Publication Date
December 2020
DOI
10.1186/s40814-020-00594-1
ISSN
2055-5784